John D. Clarke

John D. Clarke

Auto-generated profile, based on publicly available information

John D. Clarke

University of Oxford, Department of Biochemistry

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2023 in IUCrJ
Verified
Journal Article
Open access
PDF file
HMHalina Mikolajek
Halina Mikolajek
JSJuan Sanchez-Weatherby
Juan Sanchez-Weatherby
JSJames Sandy
James Sandy
RGRichard J. Gildea
Richard J. Gildea
ICIvan Campeotto
Ivan Campeotto
MHMichael Hough
Michael Hough
The utility of X-ray crystal structures determined under ambient-temperature conditions is becoming increasingly recognized. Such experiments can allow protein dynamics to be characterized and are particularly well suited to challenging protein targets that may form fragile crystals that are difficult to cryo-cool. Room-temperature data collection also enables time-resolved experiments. In contrast to the high-throughput highly automated pipelines for determination of structures at cryogenic temperatures widely available at synchrotron beamlines, room-temperature methodology is less mature. Here, the current status of the fully automated ambient-temperature beamline VMXi at Diamond Light Source is described, and a highly efficient pipeline from protein sample to final multi-crystal data analysis and structure determination is shown. The capability of the pipeline is illustrated using a range of user case studies representing different challenges, and from high and lower symmetry space groups and varied crystal sizes. It is also demonstrated that very rapid structure determination from crystals in situ within crystallization plates is now routine with minimal user intervention.

5 June 2024 in Open Biology
Verified
Journal Article
Open access
KCKaty Cornish
Katy Cornish
JHJiandong Huo
Jiandong Huo
LJLuke Jones
Luke Jones
PSPARUL SHARMA
PARUL SHARMA
JTJoseph W. Thrush
Joseph W. Thrush
Ray OwensRay Owens
Ray Owens
The Omicron strains of SARS-CoV-2 pose a significant challenge to the development of effective antibody-based treatments as immune evasion has compromised most available immune therapeutics. Therefore, in the ‘arms race’ with the virus, there is a continuing need to identify new biologics for the prevention or treatment of SARS-CoV-2 infections. Here, we report the isolation of nanobodies that bind to the Omicron BA.1 spike protein by screening nanobody phage display libraries previously generated from llamas immunized with either the Wuhan or Beta spike proteins. The structure and binding properties of three of these nanobodies (A8, H6 and B5-5) have been characterized in detail providing insight into their binding epitopes on the Omicron spike protein. Trimeric versions of H6 and B5-5 neutralized the SARS-CoV-2 variant of concern BA.5 both in vitro and in the hamster model of COVID-19 following nasal administration. Thus, either alone or in combination could serve as starting points for the development of new anti-viral immunotherapeutics.

18 October 2024 in Journal of General Virology
Verified
Journal Article
Open access
JCJohn D. Clarke
John D. Clarke
HDHelen M.E. Duyvesteyn
Helen M.E. Duyvesteyn
EPEva Perez-Martin
Eva Perez-Martin
ULUndīne Latišenko
Undīne Latišenko
CPClaudine Porta
Claudine Porta
JHJohn A. Hammond
John A. Hammond
Foot-and-mouth disease vaccination using inactivated virus is suboptimal, as the icosahedral viral capsids often disassemble into antigenically distinct pentameric units during long-term storage, or exposure to elevated temperature or lowered pH, and thus raise a response that is no longer protective. Furthermore, as foot-and-mouth disease virus (FMDV)’s seven serotypes are antigenically diverse, cross-protection from a single serotype vaccine is limited, and most existing mouse and bovine antibodies and camelid single-domain heavy chain-only antibodies are serotype-specific. For quality control purposes, there is a real need for pan-serotype antibodies that clearly distinguish between pentamer (12S) and protective intact FMDV capsid. To date, few cross-serotype bovine-derived antibodies have been reported in the literature. We identify a bovine antibody with an ultralong CDR-H3, Ab117, whose structural analysis reveals that it binds to a deep, hydrophobic pocket on the interior surface of the capsid via the CDR-H3. Main-chain and hydrophobic interactions provide broad serotype specificity. ELISA analysis confirms that Ab117 is a novel pan-serotype and conformational epitope-specific 12S reagent, suitable for assessing capsid integrity.

1 July 2024 in Acta Crystallographica Section F Structural Biology Communications
Verified
Journal Article
Open access
PDF file
JCJohn D. Clarke
John D. Clarke
ADAlice Douangamath
Alice Douangamath
HMHalina Mikolajek
Halina Mikolajek
MPMarie Bonnet-Di Placido
Marie Bonnet-Di Placido
JRJingshan Ren
Jingshan Ren
Ray OwensRay Owens
Ray Owens
The third complementary-determining regions of the heavy-chain (CDR3H) variable regions (VH) of some cattle antibodies are highly extended, consisting of 48 or more residues. These `ultralong' CDR3Hs form β-ribbon stalks that protrude from the surface of the antibody with a disulfide cross-linked knob region at their apex that dominates antigen interactions over the other CDR loops. The structure of the Fab fragment of a naturally paired bovine ultralong antibody (D08), identified by single B-cell sequencing, has been determined to 1.6 Å resolution. By swapping the D08 native light chain with that of an unrelated antigen-unknown ultralong antibody, it is shown that interactions between the CDR3s of the variable domains potentially affect the fine positioning of the ultralong CDR3H; however, comparison with other crystallographic structures shows that crystalline packing is also a major contributor. It is concluded that, on balance, the exact positioning of ultralong CDR3H loops is most likely to be due to the constraints of crystal packing.

28 January 2026 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Open access
KPKelly L. Parker
Kelly L. Parker
JCJohn D. Clarke
John D. Clarke
XLXiaojiao Liu
Xiaojiao Liu
BGBarbara F. Gomes
Barbara F. Gomes
LELauren E.-A. Eyssen
Lauren E.-A. Eyssen
Ray OwensRay Owens
Ray Owens
Schistosoma mansoni cathepsin D1 ( Sm CD1) has been shown to be an essential enzyme for helminth metabolism due to its role in haemoglobin degradation: a key amino-acid source for the developing parasite. Therefore, the enzyme is a potential target for the development of antischistosomal inhibitors. Sm CD1 has significant sequence identity to cathepsin D-like proteases found in other schistosome species and homology to mammalian aspartic proteases. Here, we report the first crystal structures of a helminth cathepsin D, Sm CD1, and have identified a single-domain antibody (nanobody) that specifically binds to Sm CD1 with nanomolar affinity but does not recognize human cathepsin D. We have mapped the epitope of the nanobody by determining the crystal structure of the enzyme–nanobody complex, revealing the conformation of Sm CD1 in the propeptide-bound state.

1 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JCJohn D. Clarke
John D. Clarke
MGMichalina Grabias
Michalina Grabias
AMAntonio Di Maio
Antonio Di Maio
HPHarley Phlora
Harley Phlora
SVSnezana Vasiljevic
Snezana Vasiljevic
AWAntoni G. Wrobel
Antoni G. Wrobel
Coronavirus spike proteins mediate receptor binding and fusion and are key determinants of viral host range. To bind protein receptors, some CoV spikes undergo conformational changes termed opening, which expose the receptor-binding surface. Yet, the prerequisites and mechanism of spike opening remain poorly understood, especially outside of beta-CoVs, and many CoV spikes have been observed only in the closed conformation. The receptor specificities of gamma-CoVs, for which birds are natural hosts, await in-depth characterisation and their spikes have not been observed to open. Here, we report structures of the spike from an unusual mammalian gamma-CoV isolated from a beluga whale (BwCoV), in closed and open conformations, the latter with two S1B domains erect. BwCoV spike opening is associated with changes throughout S1 that resemble those observed in beta-CoV spikes and similarly propagate into destabilisation of the fusogenic S2 core. Furthermore, the BwCoV-S structure contains an additional density likely corresponding to a fatty acid, consistent with lipid binding stabilising the closed conformation through a pocket distinct from that identified for beta-CoVs. These structural insights reveal conserved principles regulating spike dynamics across coronavirus genera and support lipid binding as a potential modulatory mechanism of spike opening.